ARL3 and fibrodysplasia ossificans progressiva: Additionally, in the study discussed earlier in our review, which indicated primary cilia as a potential therapeutic avenue in the pathogenesis of FOP, researchers employed a siRNA-based drug targeting Arl3. The treatment proved effective in reducing HO formation in Acvr1Q207D mice (He et al. 2024).